Enveric Biosciences, Inc. of CAMBRIDGE, MA, a company, filed a Form D amendment with the SEC on 2023-04-19. The offering totals $12.8M, of which $12.8M was reported sold. Industry: Pharmaceuticals.
Showing 25 of 58 people.
| Name | Role | Location |
|---|---|---|
| George Kegler | Director | Naples, FL |
| Douglas Lind | Director | Naples, FL |
| Bevin O'Neil | Director | Naples, FL |
| Frank Pasqualone | Director | Cambridge, MA |
| Marcus Schabacker | Director | Naples, FL |
| Joseph Tucker | Director | Naples, FL |
| Kevin Coveney | Executive Officer | Naples, FL |
| Bob Dagher | Executive Officer | Naples, FL |
| Peter Facchini | Executive Officer | Naples, FL |
| Avani Kanubaddi | Executive Officer | Naples, FL |
| Joseph Tucker | Executive Officer | Naples, FL |
| David Johnson | Director | Greenwood Village, CO |
| David Johnson | Executive Officer | Greenwood Village, CO |
| Sheila W DeWitt | Director | Cambridge, MA |
| George W Kegler | Director | Cambridge, MA |
| Kevin M Coveney | Executive Officer | Cambridge, MA |
| Marcus W Schabacker | Director | Cambridge, MA |
| Frank W Pasqualone | Director | Cambridge, MA |
| Michael D Webb | Director | Cambridge, MA |
| Joseph E Tucker | Director | Cambridge, MA |
| Joseph E Tucker | Executive Officer | Cambridge, MA |
| David Luci | Director | Jersey City, NJ |
| VIRAJ PATEL | Executive Officer | Seattle, WA |
| Dimitrios Angelis | Director | Denver, CO |
| Brent Kelton | Executive Officer | Austin, TX |
| Filed | Form | Offering | Sold |
|---|---|---|---|
| 2026-05-04 | D | $5.0M | $5.0M |
| 2026-02-11 | D | $1.5M | $1.5M |
| 2025-12-23 | D | $107K | $107K |
| 2025-10-03 | D | — | — |
| 2022-08-05 | D | $8.6M | $8.6M |
| 2021-02-24 | D | $8.4M | — |
| 2021-01-20 | D | $8.2M | — |
| 2018-08-28 | D/A | $6.6M | $6.6M |
| 2018-08-02 | D | $6.0M | $6.0M |